These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20065240)

  • 1. Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
    Chu SH; Li AH
    Arch Ophthalmol; 2010 Jan; 128(1):146; author reply 146-7. PubMed ID: 20065240
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosiglitazone and delayed onset of proliferative diabetic retinopathy.
    Shen LQ; Child A; Weber GM; Folkman J; Aiello LP
    Arch Ophthalmol; 2008 Jun; 126(6):793-9. PubMed ID: 18541841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular edema and thiazolidinediones.
    Colucciello M; Ryan E
    Arch Ophthalmol; 2010 Dec; 128(12):1630-1; author reply 1631-2. PubMed ID: 21149797
    [No Abstract]   [Full Text] [Related]  

  • 4. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
    Lehmann DF; Lohray BB
    J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone associated diabetic macular oedema.
    Gokce G; Durukan AH; Erdurman FC; Ceylan OM; Sobaci G
    West Indian Med J; 2012 Sep; 61(6):648-9. PubMed ID: 23441365
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.
    Tatti P; Arrigoni F; Longobardi A; Costanza F; Di Blasi P; Merante D
    Clin Drug Investig; 2008; 28(5):327-32. PubMed ID: 18407718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study.
    Gower EW; Lovato JF; Ambrosius WT; Chew EY; Danis RP; Davis MD; Goff DC; Greven CM;
    Am J Ophthalmol; 2018 Mar; 187():138-147. PubMed ID: 29275147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].
    Szymborska-Kajanek A; Strojek K
    Kardiol Pol; 2006 Mar; 64(3):322-5; discussion 325-6. PubMed ID: 16583340
    [No Abstract]   [Full Text] [Related]  

  • 9. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
    Odom J; Williamson B; Carter L
    Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case].
    Nyssen V; Hautenauven F; Lekeu Hinostroza JP; Guagnini AP
    Bull Soc Belge Ophtalmol; 2009; (313):39-44. PubMed ID: 20108571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones and macular edema: comment on "Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes".
    Singh S; Segal JB
    Arch Intern Med; 2012 Jul; 172(13):1011-3. PubMed ID: 22688825
    [No Abstract]   [Full Text] [Related]  

  • 12. The PROactive study: some answers, many questions.
    Yki-Järvinen H
    Lancet; 2005 Oct; 366(9493):1241-2. PubMed ID: 16214581
    [No Abstract]   [Full Text] [Related]  

  • 13. Future directions for insulin sensitizers in disease prevention.
    Colca JR
    Curr Opin Investig Drugs; 2007 Sep; 8(9):707-10. PubMed ID: 17729181
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence based therapy with insulin in diabetic patients].
    Jermendy G
    Orv Hetil; 2005 Feb; 146(8):341-52. PubMed ID: 15803885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
    Kitzmiller JL; Main E; Ward B; Theiss T; Peterson DL
    Diabetes Care; 1999 May; 22(5):874-6. PubMed ID: 10332713
    [No Abstract]   [Full Text] [Related]  

  • 16. Glitazone use associated with diabetic macular edema.
    Fong DS; Contreras R
    Am J Ophthalmol; 2009 Apr; 147(4):583-586.e1. PubMed ID: 19181303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli A; Formoso G
    Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy and insulin glargine.
    Chantelau E
    Diabetologia; 2009 Oct; 52(10):2233; author reply 2236-9. PubMed ID: 19680626
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiazolidinediones: a novel class of drugs for the prevention of diabetic nephropathy?
    Zheng F; Guan Y
    Kidney Int; 2007 Dec; 72(11):1301-3. PubMed ID: 18004308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
    Idris I; Warren G; Donnelly R
    Arch Intern Med; 2012 Jul; 172(13):1005-11. PubMed ID: 22688528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.